Baker McKenzie has advised the shareholders of Biopharma, a Ukrainian manufacturer of pharmaceuticals and healthcare products, on the carve-out of its non-plasma business and its sale to Stada AG, a global manufacturer of pharmaceuticals and consumer healthcare products. Arzinger reportedly advised Stada on the deal.
Baker McKenzie's team was co-led by Kyiv Partners Viacheslav Yakymchuk and Olha Demianiuk and included Kyiv-based Partner Oksana Simonova, Senior Associate Olha Mikheieva, Associates Andrii Finogin, Olha Sviatenka, and Khrystyna Penyk, as well as London-based Senior Corporate Associate Robert Gray.
